What happens to orally supplemented GABA in the blood after it enters the human body? Existing pharmacokinetic studies show that oral γ-aminobutyric acid (GABA) exhibits the following characteristics in healthy humans: rapid absorption, mild metabolism, fast clearance with no significant accumulation tendency, and plasma GABA levels after oral administration are not affected by sex, diet, exercise, or circadian rhythm. This indicates that the dynamic changes of oral GABA in the body are relatively stable and minimally influenced by external factors.

Absorption

Oral GABA is absorbed rapidly. A study published in Frontiers in Pharmacology showed that after a single oral dose of 2 grams of GABA in healthy volunteers, the plasma concentration peaked within 0.5 to 1 hour, with a peak concentration (Cmax) of approximately 688 ng/ml. The peak concentration after repeated administration (3 times daily for 7 consecutive days) was 767 ng/ml, which was not significantly different from that after single administration, indicating that the absorption rate of GABA is stable and does not change significantly with dosing frequency. Furthermore, the area under the concentration-time curve (AUC) data further confirmed that GABA is effectively absorbed into the human bloodstream, with levels significantly higher than those in the placebo group.

Metabolism

The metabolism of GABA in the human body is primarily catalyzed by GABA transaminase, which converts GABA into succinic semialdehyde. This is further metabolized to succinate to enter the tricarboxylic acid cycle, or to pharmacologically inactive products such as alanine. There is no significant sex difference in the metabolism of oral GABA, and the metabolic process does not affect other physiological indicators. A small number of volunteers experienced mild and transient elevations in liver enzymes, but these resolved spontaneously without intervention and were found to have no clinical significance.

Clearance

Experiments measuring both single administration (2 grams of oral GABA once) and repeated administration (2 grams three times daily for 7 consecutive days) found that the plasma half-life (t1/2) of GABA is approximately 5 to 5.2 hours. Moreover, after repeated administration, there is no significant accumulation tendency in the human body, with an accumulation ratio (RA) of 1.11. These data collectively demonstrate that GABA is a substance that can be metabolized and cleared by the human body in a timely manner and does not remain in the body for long periods.

In summary, the absorption and metabolism characteristics of exogenous GABA make it suitable for daily supplementation scenarios that require short-term, controllable effects without long-term accumulation in the body. It provides consumers with a safe, controllable, and non-addictive nutritional option. However, more clinical studies are still needed to verify the blood-brain barrier penetration and long-term effects of GABA.

References

[1] Junfeng L, Zhaoyun Z, Xiaoxia L, et al. Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics[J]. Frontiers in Pharmacology, 2015, 6. DOI:10.3389/fphar.2015.00260.

[2] Almutairi S, Sivadas A, Kwakowsky A. The Effect of Oral GABA on the Nervous System: Potential for Therapeutic Intervention[J]. Nutraceuticals, 2024, 4(2):241-259.